Differential Significance of Plasma Visfatin Concentrations according to Adiposity in Children and Adolescents
Hae Jin Kim, Sun Young Park, Yong Jun Choi et al. · Hormone Research in Paediatrics · 2013
BACKGROUND/AIMS: Visfatin is an adipocytokine predominantly expressed in visceral adipose tissue. We examined the relationship between plasma visfatin concentrations and anthropometric and metabolic parameters in children and adolescents, who are relatively less influenced by the effects of accompanying disease. METHODS: We studied 135 children and adolescents (8-16 years old). Plasma glucose, insulin, lipid profile, visfatin and other adipocytokine levels were measured. CT scans were performed to evaluate the distribution of abdominal fat. We analyzed the relationship between circulating visfatin levels and anthropometric and metabolic parameters according to central adiposity (total abdominal fat by CT scan). RESULTS: In the lower-adiposity group, plasma visfatin concentrations were significantly correlated with total abdominal fat, visceral fat, subcutaneous abdominal fat, plasma triglyceride level and homeostasis model assessment of insulin resistance (HOMA-IR). In a multiple linear regression analysis, visceral fat and triglycerides were independently associated with plasma visfatin levels. In the higher-adiposity group, plasma visfatin concentrations were not correlated with visceral fat or HOMA-IR but were significantly correlated with circulating interleukin-6 levels. CONCLUSION: These data suggest that the relationship between plasma visfatin concentrations and metabolic parameters differs according to central adiposity and that plasma visfatin concentrations are correlated with visceral fat and triglyceride levels, especially in children and adolescents with lower adiposity.
Cited by 3,048 works. doi:10.1159/000348848
Authors
References
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in Sepsis
- APACHE II: a severity of disease classification system.
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis
- Caspases: Enemies Within
- Heat Shock Protein A12B Protects Vascular Endothelial Cells Against Sepsis-Induced Acute Lung Injury in Mice
- Obesity is associated with macrophage accumulation in adipose tissue
- Multiple Organ Dysfunction Score
- A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry